Information Provided By:
Fly News Breaks for January 27, 2020
JNJ
Jan 27, 2020 | 07:07 EDT
Credit Suisse analyst Matt Miksic raised his price target for Johnson & Johnson to $170 from $163, citing a "solid end to a strong year." The analyst notes that 2020 guide calls for solid fundamentals and that management remains engaged on the litigation front. He expects stock performance to improve with declining uncertainty regarding the range of potential liability facing the company. Miksic has an Outperform rating on the shares.
News For JNJ From the Last 2 Days
JNJ
JNJ
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.